Praxis Precision Medicines, Inc.
The Principal Scientist, Formulation Development leads drug product development from early discovery through late-stage clinical stages, translating compounds into robust formulations and scalable manufacturing processes. This role involves shaping development strategy, solving complex technical challenges, and overseeing work at CDMOs while partnering closely with cross-functional teams. The position requires deep formulation expertise and hands-on scientific leadership to move programs forward with urgency and sound judgment.
Praxis Precision Medicines is a fully integrated, leading CNS precision neuroscience biopharmaceutical company that translates insights from genetic epilepsies into therapies for central nervous system disorders characterized by neuronal excitation-inhibition imbalance. The company advances a diversified pipeline across epilepsy and movement disorders using two proprietary platforms: Cerebrum™ (small molecules) and Solidus™ (antisense oligonucleotides). Guided by its DARE FOR MORE® philosophy, Praxis applies human genetics, translational science, and patient-guided development to deliver precision therapies for patients with complex brain disorders.
Praxis Precision Medicines, Inc. (PRAX) Gains Analyst Confidence With Ulixacaltamide
3 weeks ago
Biotech Praxis gives 2,931 stock units to 14 new employees
1 week ago
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
1 week ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Praxis Precision Medicines, Inc..
3,826 Shares in Praxis Precision Medicines, Inc. $PRAX Purchased by ProShare Advisors LLC
2 weeks ago
Formulation and Process Development Scientist
Revolution Medicines
(Associate) Director, Drug Product, CMC
Centessa Pharmaceuticals
Scientist, Early Stage Formulation
AstraZeneca
Senior / Principal Scientist, Formulation and Drug Product Development
immunomeinc
Sterile Product Development Scientist
MSD
Director, Formulations
Cytokinetics